We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




China Medical Technologies Acquires Beijing Bio-Ekon Biotechnology

By HospiMedica staff writers
Posted on 03 Dec 2007
China Medical Technologies, Inc. More...
(Beijing, China), a medical device company that develops, manufactures, and markets in-vitro diagnostic (IVD) products and a high-intensity focused ultrasound tumor therapy system, has entered into an agreement to purchase Beijing Bio-Ekon Biotechnology Co., Ltd. (BBE; Beijing, China) for US$28.8 million.

BBE has strong research and development capability and is developing enhanced chemiluminescence immunoassay (ECLIA) reagents for human immunodeficiency virus (HIV) and hepatitis C tests. The company has already developed a fully automatic ECLIA analyzer with processing capacity of 120 tests per hour. It applied magnetic antibody immunoassay (MAIA) separation technology to develop the analyzer.

The market potential of BBE's new reagents is very promising. The company has completed the development of an ECLIA reagent for testing blood fluke parasitic infection. Blood flukes post a major threat to the vast population living in the waterfront areas in the Yangtze River region of China. BBE has also developed reagents for testing toxic aflatoxin in cereal products and clenbuterol in pork.

"The acquisition is in line with our strategy to expand in the advanced IVD segment and increase our ECLIA products' penetration in hospitals across China,” stated Mr. Xiaodong Wu, chairman and CEO of China Medical Technologies. "BBE has a solid customer base of over 800 hospitals and certain of its reagents and MAIA-based fully automatic ECLIA analyzer can expand our product portfolio and provide us with new business opportunities in the testing of parasitic infections and food safety. BBE's direct sales experience will also be beneficial to us in formulating our sales strategies.”


Related Links:
China Medical Technologies

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
POC Immunoassay Analyzer
Procise DX
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.